Li Xueshu, Turánek Jaroslav, Knötigová Pavlína, Kudlácková Hana, Masek Josef, Parkin Sean, Rankin Stephen E, Knutson Barbara L, Lehmler Hans-Joachim
Department of Occupational and Environmental Health, University of Iowa, Iowa City, IA 52242, USA.
Colloids Surf B Biointerfaces. 2009 Oct 1;73(1):65-74. doi: 10.1016/j.colsurfb.2009.04.023. Epub 2009 May 5.
A series of hydrocarbon and fluorocarbon carbohydrate surfactants with different headgroups (i.e., gluco-, galacto- and maltopyranoside) and (fluorinated) alkyl tails (i.e., C7 and C14 to C19) was synthesized to investigate trends in their cytotoxicity and haemolytic activity, and how surfactant-lipid interactions of selected surfactants contribute to these two measures of biocompatibility. All surfactants displayed low cytotoxicity (EC50 = 25 to >250 microM) and low haemolytic activity (EC50 = 0.2 to >3.3 mM), with headgroup structure, tail length and degree of fluorination being important structural determinants for both endpoints. The EC50 values of hydrocarbon and fluorocarbon glucopyranoside surfactants displayed a "cut-off" effect (i.e., a maximum with respect to the chain length). According to steady-state fluorescence anisotropy studies, short chain (C7) surfactants partitioned less readily into model membranes, which explains their low cytotoxicity and haemolytic activity. Interestingly, galactopyranosides were less toxic compared to glucopyranosides with the same hydrophobic tail. Although both surfactant types only differ in the stereochemistry of the 4-OH group, hexadecyl gluco- and galactopyranoside surfactants had similar apparent membrane partition coefficients, but differed in their overall effect on the phase behaviour of DPPC model membranes, as assessed using steady-state fluorescence anisotropy studies. These observations suggest that highly selective surfactant-lipid interactions may be responsible for the differential cytotoxicity and, possible, haemolytic activity of hydrocarbon and fluorocarbon carbohydrate surfactants intended for a variety of pharmaceutical and biomedical applications.
合成了一系列具有不同头基(即葡萄糖基、半乳糖基和麦芽吡喃糖苷)和(氟化)烷基尾链(即C7以及C14至C19)的碳氢化合物和碳氟化合物碳水化合物表面活性剂,以研究它们的细胞毒性和溶血活性趋势,以及所选表面活性剂与脂质的相互作用如何影响这两种生物相容性指标。所有表面活性剂均表现出低细胞毒性(EC50 = 25至>250 microM)和低溶血活性(EC50 = 0.2至>3.3 mM),头基结构、尾链长度和氟化程度是这两个指标的重要结构决定因素。碳氢化合物和碳氟化合物葡萄糖吡喃糖苷表面活性剂的EC50值呈现出“截止”效应(即相对于链长存在最大值)。根据稳态荧光各向异性研究,短链(C7)表面活性剂较难分配到模型膜中,这解释了它们较低的细胞毒性和溶血活性。有趣的是,与具有相同疏水尾链的葡萄糖吡喃糖苷相比,半乳糖吡喃糖苷的毒性较小。尽管这两种表面活性剂类型仅在4-OH基团的立体化学上有所不同,但十六烷基葡萄糖吡喃糖苷和半乳糖吡喃糖苷表面活性剂具有相似的表观膜分配系数,但在用稳态荧光各向异性研究评估时,它们对DPPC模型膜相行为的总体影响有所不同。这些观察结果表明,高度选择性的表面活性剂与脂质的相互作用可能是碳氢化合物和碳氟化合物碳水化合物表面活性剂在各种药物和生物医学应用中表现出不同细胞毒性以及可能的溶血活性的原因。